Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome.

Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome.

<h4>Background</h4>Methylprednisolone remains a commonly used ancillary therapy for paediatric acute respiratory distress syndrome (PARDS), despite a lack of level 1 evidence to justify its use. When planning prospective trials it is useful to define response to therapy and to identify i...

Full description

Bibliographic Details
Main Authors: Rebecca B Mitting, Samiran Ray, Michael Raffles, Helen Egan, Paul Goley, Mark Peters, Simon Nadel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0225737

Internet

https://doi.org/10.1371/journal.pone.0225737

Similar Items